Reoperation with Total Hysterectomy after Incomplete Surgery Is Helpful in Patients with Incidentally Diagnosed Uterine Leiomyosarcoma

Author:

Zhang Wei,Han Zhihong,Li Ziting,Zheng Zhong,Wu Xiaohua

Abstract

<b><i>Objective:</i></b> The aim of this study was to evaluate the impact of initial surgical treatments and surgical re-exploration on the oncological outcomes of patients with incidentally diagnosed uterine leiomyosarcoma (uLMS). <b><i>Design:</i></b> A retrospective analysis of 87 patients who underwent re-exploration for incidentally diagnosed uLMS at the Fudan University Shanghai Cancer Center was performed. <b><i>Methods:</i></b> Kaplan-Meier and Cox proportional hazards regression models were used for analyses. <b><i>Results:</i></b> The median age (range) at diagnosis was 49 (23–76) years. The median disease-free survival (DFS) and overall survival (OS) were 15.1 and 56.7 months, respectively. The Kaplan-Meier curves and log-rank tests showed the median DFS was longer in patients with restaging operation (<i>N</i> = 30) than without (<i>N</i> = 55) (<i>p</i> = 0.017) but no significant difference in median OS (<i>p</i> = 0.142). In patients who underwent myomectomy/subtotal hysterectomy, 5 patients (28.5%) had remnant sarcoma during re-exploration with complete uterine removal, and re-exploration was associated with longer DFS (<i>p</i> = 0.038) and OS (<i>p</i> = 0.042). <b><i>Limitations:</i></b> The limitation of this study is its retrospective observational design with a limited number of patients. <b><i>Conclusion:</i></b> Reoperation with total hysterectomy after incomplete surgery may be helpful in patients with incidentally diagnosed uLMS at the first treatment.

Publisher

S. Karger AG

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference9 articles.

1. Zhao F, Xu Y, Zhang H, Ren Y. Ultrasonographic findings of uterine carcinosarcoma. Gynecol Obstet Invest. 2019;84:277–82.

2. Momtahen S, Curtin J, Mittal K. Current chemotherapy and potential new targets in uterine leiomyosarcoma. J Clin Med Res. 2016;8:181–9.

3. Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017;145:208–16.

4. Hensley ML, Barrette BA, Baumann K, Gaffney D, Hamilton AL, Kim JW, et al. Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas. Int J Gynecol Cancer. 2014;24:S61–6.

5. Lee JY, Kim HS, Nam EJ, Kim SW, Kim S, Kim YT. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease. BMC cancer. 2016;16:675.

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3